Product Description
The global needleless connector market was valued at $1.3 billion in 2025. This is expected to increase over the forecast period at a CAGR of 3.9% to reach $1.8 billion by 2032.
The full report suite on the global market for needleless connectors includes standalone and integrated devices.
The report includes data for 65 countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Needleless Connector Market Trends

Needleless connectors are trending toward anti-reflux, positive displacement designs to improve patient safety by minimizing catheter occlusions and blood exposure. Over the period, it is expected that devices will start to lean towards these designs.
Global Needleless Connector Market Share Insights

Becton Dickinson was the leading company in the needleless connector market. Becton Dickinson is also an infusion pump manufacturer and is able to sell more of its NLCs through device bundling. The company is the largest player in the global infusion therapy market generally, which affords the company significant brand recognition, as well as a flexibility to manufacture and sell various disposable products in large volumes for competitive prices.
ICU Medical was the second-leading company in the needleless connector market. In the mechanical valve segment, ICU Medical sells the Clave™ connector. The design of Clave™ takes the external blunt cannula and integrates it into the split septum construction. This allows the device to be accessed by any standard male Luer connector.
B. Braun was the third-leading company in the needleless connector market. Its Ultrasite™ is a positive displacement device that allows high-flow fluid delivery through a male Luer connection. Ultrasite™ AG is the antibacterial version of this device
Global Needleless Connector Market Segmentation Summary
- Needleless Connector Market – Further Segmented Into:
- Device Type: Standalone and Integrated
- Care Setting: Hospital and Non-Hospital
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.